DAFNA Capital Management LLC 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
DAFNA Capital Management LLC disclosed 83 US equity positions worth $352.7m in its Q1 2025 13F filing. The largest position was XBI at 9.3% of the reported book, followed by STXS and RVMD. Against the Q4 2024 filing, it opened 2 new positions, added to 18 and reduced 12 among the top 50 holdings.
What did DAFNA Capital Management LLC own in Q1 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | XBI SPDR S&P BIOTECH ETF | 9.3% | $32.8m | 404,505 | 2% | added | |
| 2 | STXS STEREOTAXIS INC | 6.8% | $24.1m | 13,680,554 | 0% | held | |
| 3 | RVMD REVOLUTION MEDICINES INC | Healthcare | 6.6% | $23.2m | 656,176 | 4% | added |
| 4 | MERUS N V | 5.5% | $19.4m | 461,804 | 2% | added | |
| 5 | ATRC ATRICURE INC | Healthcare | 5.4% | $19.1m | 592,273 | -8% | reduced |
| 6 | CYTK CYTOKINETICS INC | Healthcare | 4.5% | $16.0m | 398,100 | 0% | held |
| 7 | 2655787D BLUEPRINT MEDICINES CORP | 3.8% | $13.5m | 152,263 | 2% | added | |
| 8 | IBB ISHARES NASDAQ BIOTECH INDX | 3.7% | $13.1m | 102,500 | 0% | held | |
| 9 | AXGN AXOGEN INC | Healthcare | 3.6% | $12.6m | 680,782 | -20% | reduced |
| 10 | ASND ASCENDIS PHARMA A/S | Healthcare | 3.6% | $12.5m | 80,398 | -22% | reduced |
| 11 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 2.7% | $9.7m | 589,330 | 18% | added |
| 12 | XENE XENON PHARMACEUTICALS INC | Healthcare | 2.6% | $9.2m | 273,739 | 0% | held |
| 13 | 4XC1 KALVISTA PHARMACEUTICALS INC | 2.5% | $8.7m | 752,359 | -7% | reduced | |
| 14 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.2% | $7.9m | 71,615 | 0% | held |
| 15 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 1.9% | $6.7m | 544,502 | 0% | held |
| 16 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 1.6% | $5.8m | 731,363 | 0% | held | |
| 17 | TNDM TANDEM DIABETES CARE INC | Healthcare | 1.6% | $5.6m | 294,208 | 32% | added |
| 18 | URGN UROGEN PHARMA LTD | Healthcare | 1.5% | $5.4m | 492,515 | 0% | held |
| 19 | BHVN BIOHAVEN LTD | Healthcare | 1.5% | $5.3m | 220,235 | 0% | held |
| 20 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.4% | $4.9m | 309,200 | 111% | added |
| 21 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 1.4% | $4.9m | 625,126 | 146% | added |
| 22 | ASND ASCENDIS PHARMA A/S | 1.3% | $4.7m | 4,000,000 | 0% | held | |
| 23 | DXCM DEXCOM INC | Healthcare | 1.3% | $4.5m | 65,552 | 0% | held |
| 24 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.2% | $4.2m | 558,255 | -16% | reduced |
| 25 | EWTX EDGEWISE THERAPEUTICS INC | 1.1% | $4.0m | 183,140 | -2% | reduced | |
| 26 | LKFT GALAPAGOS NV | Healthcare | 0.9% | $3.3m | 130,175 | 0% | held |
| 27 | INGN INOGEN INC | Healthcare | 0.9% | $3.3m | 458,065 | 119% | added |
| 28 | PODD INSULET CORP | Healthcare | 0.9% | $3.1m | 11,900 | -4% | reduced |
| 29 | ALKS ALKERMES PLC | Healthcare | 0.9% | $3.1m | 94,200 | -22% | reduced |
| 30 | KURA KURA ONCOLOGY INC | Healthcare | 0.9% | $3.1m | 463,368 | 3% | added |
| 31 | STOK STOKE THERAPEUTICS INC | Healthcare | 0.8% | $3.0m | 443,998 | 160% | added |
| 32 | IMVT IMMUNOVANT INC | Healthcare | 0.8% | $2.9m | 169,996 | 57% | added |
| 33 | BCAX BICARA THERAPEUTICS INC | 0.8% | $2.8m | 212,001 | 101% | added | |
| 34 | ARAY ACCURAY INC | Healthcare | 0.6% | $2.2m | 1,222,358 | 0% | held |
| 35 | TSVT* 2SEVENTY BIO INC | 0.6% | $2.1m | 429,252 | 0% | held | |
| 36 | PROQR THERAPEUTICS N V | 0.6% | $2.1m | 1,567,561 | 0% | held | |
| 37 | CMPS COMPASS PATHWAYS PLC | Healthcare | 0.6% | $2.0m | 711,046 | 192% | added |
| 38 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 0.6% | $2.0m | 1,380,118 | 11% | added |
| 39 | TELA TELA BIO INC | 0.5% | $1.8m | 1,441,029 | 0% | held | |
| 40 | ALGN ALIGN TECHNOLOGY INC | Healthcare | 0.5% | $1.7m | 11,000 | 100% | added |
| 41 | DNLI DENALI THERAPEUTICS INC | Healthcare | 0.5% | $1.7m | 127,900 | – | new |
| 42 | CATBUSD ASTRIA THERAPEUTICS INC | 0.5% | $1.7m | 314,775 | 5% | added | |
| 43 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.4% | $1.6m | 64,516 | 0% | held |
| 44 | RGLS REGULUS THERAPEUTICS INC | 0.4% | $1.5m | 847,176 | -3% | reduced | |
| 45 | BWAY BRAINSWAY LTD | 0.4% | $1.5m | 156,533 | -19% | reduced | |
| 46 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 0.4% | $1.4m | 242,000 | – | new |
| 47 | KROS KEROS THERAPEUTICS INC | Healthcare | 0.4% | $1.3m | 130,316 | 0% | held |
| 48 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.4% | $1.3m | 378,083 | -4% | reduced |
| 49 | 2662247D ITEOS THERAPEUTICS INC | 0.4% | $1.3m | 213,347 | 13% | added | |
| 50 | PVLA PALVELLA THERAPEUTICS INC | 0.3% | $1.2m | 43,348 | -39% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.